Medevice

MEDEVICE Capital emerged in 2011 as France's pioneering seed investment fund dedicated exclusively to MedTech and e-Health ventures. Established by healthcare industry entrepreneurs, the firm's mission centers on developing companies with robust business models that significantly enhance patient care outcomes. The founding team brings an exceptional combination of expertise, including successful track records in medical technology enterprises, intimate knowledge of French financing mechanisms, and extensive corporate experience spanning business development, sales strategies, marketing initiatives, auditing processes, and operational management.

What distinguishes MEDEVICE's investment approach is their commitment to proximity and active mentorship. The team maintains daily connections with portfolio company management, providing continuous coaching rather than periodic oversight. This hands-on methodology enables MEDEVICE to offer timely guidance on critical business decisions, helping early-stage healthcare companies navigate the complex regulatory and commercial landscapes characteristic of medical technology development. Their involvement extends beyond capital provision to include strategic planning, market access strategies, and operational optimization.

The foundation of MEDEVICE's relationships with portfolio companies rests on three pillars: credibility derived from their specialized healthcare background, a dedicated hands-on approach to driving business success, and complete alignment of long-term interests. This trust-based environment develops organically as founders benefit from the fund's industry-specific insights and entrepreneurial perspective. MEDEVICE's partners leverage their extensive networks within the European healthcare ecosystem to facilitate valuable connections with potential customers, partners, and follow-on investors.

MEDEVICE's investment philosophy centers on the belief that innovation paired with operational efficiency creates sustainable success. The firm evaluates potential investments through a dual lens: the capacity to meaningfully improve patient care and the ability to achieve financial performance that ensures long-term viability. This balanced approach has positioned MEDEVICE as a valued partner for early-stage medical technology entrepreneurs seeking not just capital, but also strategic guidance from investors who truly understand the unique challenges and opportunities in healthcare innovation. Their portfolio reflects a commitment to technologies that address significant clinical needs while demonstrating clear pathways to market adoption.